Search results for "Neurosciences & Neurology"

showing 10 items of 14 documents

PDXK mutations cause polyneuropathy responsive to pyridoxal 5′‐phosphate supplementation

2019

OBJECTIVE: To identify disease-causing variants in autosomal recessive axonal polyneuropathy with optic atrophy and provide targeted replacement therapy. METHODS: We performed genome-wide sequencing, homozygosity mapping, and segregation analysis for novel disease-causing gene discovery. We used circular dichroism to show secondary structure changes and isothermal titration calorimetry to investigate the impact of variants on adenosine triphosphate (ATP) binding. Pathogenicity was further supported by enzymatic assays and mass spectroscopy on recombinant protein, patient-derived fibroblasts, plasma, and erythrocytes. Response to supplementation was measured with clinical validated rating sc…

0301 basic medicineMale[SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/NeurobiologyLOCAL TRANSLATIONMedizinmedicine.disease_causeDISEASEchemistry.chemical_compound0302 clinical medicinepolineuropathyCinètica enzimàticaGene Regulatory NetworksPyridoxal phosphateChildPyridoxal KinaseAdenosine triphosphate (ATP)Research ArticlesAged 80 and overMutationGene Regulatory NetworkPLASMAAutosomal recessive axonal polyneuropathyDisease gene identificationPyridoxal kinase3. Good healthSettore MED/26 - NEUROLOGIANeuropaties perifèriquesTreatment OutcomePolyneuropathieNeurologyChild PreschoolPyridoxal PhosphateRELIABILITYVitamin B ComplexFemaleLife Sciences & BiomedicinePolyneuropathyHumanResearch ArticleAdultAdolescentPDXKClinical NeurologyCHARCOT-MARIE-TOOTHCHARCOT-MARIE-TOOTH CMT NEUROPATHY SCORE LOCAL TRANSLATION DISEASE RELIABILITY; MECHANISMS DISCOVERY FRAMEWORK KINASE PLASMAMECHANISMS03 medical and health sciencesPolyneuropathiesAtrophy[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry Molecular Biology/Genomics [q-bio.GN]KINASEmedicineHumansCMT NEUROPATHY SCOREPDXK mutationsPyridoxalDietary SupplementAgedPeripheral neuropathiesScience & Technology[SCCO.NEUR]Cognitive science/NeuroscienceEnzyme kineticsNeurosciencesFRAMEWORKmedicine.diseaseMolecular biology030104 developmental biologychemistryDISCOVERYDietary SupplementsMutationNeurosciences & NeurologyNeurology (clinical)Adenosine triphosphate030217 neurology & neurosurgeryAnnals of Neurology
researchProduct

Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings

2021

The European Community’s Seventh Framework Programme under grant agreement No. HEALTH-F2-2010-241909 (EUGEI); The Spanish sample was supported by the Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III (SAM16PE07CP1, PI16/02012, PI19/024) (...)

0301 basic medicinevaliditymedicine.medical_treatmentCHILDHOODNeuropsychological TestsFAMÍLIAepisodeCognition0302 clinical medicineDEFICITSSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.MedicineCognitive impairmentPsychiatrySymptom severityCannabis useIMPAIRMENTABILITYPsychiatry and Mental healthSchizophreniaRELIABILITYNeuropsychological TestLife Sciences & BiomedicineHumanClinical psychologyAdultBiochemistry & Molecular Biologyimpairmentschizophrenia-patientsabilityGENETIC RISKPsychotic DisorderSCHIZOPHRENIA-PATIENTS03 medical and health sciencesCellular and Molecular NeuroscienceSDG 3 - Good Health and Well-beingSettore M-PSI/08 - Psicologia ClinicaHumansIn patientCognitive skillVALIDITYAntipsychoticMolecular BiologySettore MED/25 - PsichiatriaAgedCross-Sectional StudieDECLINEScience & Technologyreliabilitybusiness.industryWorking memorySiblingsNeurosciencesDiagnostic markersmedicine.diseaseCross-Sectional Studies030104 developmental biologydeficitsPsychotic DisordersSchizophreniaPSYCHOSIS COGNITION MULTICENTRIC STUDYNeurosciences & NeurologybusinessEPISODE030217 neurology & neurosurgeryMolecular Psychiatry
researchProduct

Safety, tolerability, pharmacokinetics, pharmacodynamics, and exploratory efficacy of the novel enzyme replacement therapy avalglucosidase alfa (neoG…

2019

This multicenter/multinational, open-label, ascending-dose study (NCT01898364) evaluated safety, tolerability, pharmacokinetics, pharmacodynamics, and exploratory efficacy of repeat-dose avalglucosidase alfa (neoGAA), a second-generation, recombinant acid α-glucosidase replacement therapy, in late-onset Pompe disease (LOPD). Patients ≥18 years, alglucosidase alfa naïve (Naïve) or previously receiving alglucosidase alfa for ≥9 months (Switch), with baseline FVC ≥50% predicted and independently ambulatory, received every-other-week avalglucosidase alfa 5, 10, or 20 mg/kg over 24 weeks. 9/10 Naïve and 12/14 Switch patients completed the study. Avalglucosidase alfa was well-tolerated; no deaths…

Avalglucosidase alfa (neoGAA)0301 basic medicineMaleGLUCOSE TETRASACCHARIDELysosomal acid alpha-glucosidase (GAA) deficiencyCHILDRENPulmonary function testingMOTOR FUNCTION0302 clinical medicineMedicineGenetics (clinical)Late-onset Pompe disease (LOPD)Glycogen Storage Disease Type IIAlglucosidase alfaMOUSE MODELEnzyme replacement therapyMiddle AgedTreatment OutcomeNeurologyTolerabilityEnzyme replacement therapySKELETAL-MUSCLEFemaleLife Sciences & BiomedicineMUSCLE TRAINING RMTGlycogen6-MINUTE WALKmedicine.drugAdultmedicine.medical_specialtyClinical NeurologyGLYCOGEN03 medical and health sciencesFEV1/FVC ratioPharmacokineticsInternal medicineHumansEnzyme Replacement TherapyAdverse effectAlglucosidase alfaScience & Technologybusiness.industryNeurosciencesalpha-GlucosidasesADULTSGlycogen storage disease type IISEVERITY030104 developmental biologyPharmacodynamicsPediatrics Perinatology and Child HealthNeurosciences & NeurologyNeurology (clinical)Glucan 14-alpha-Glucosidasebusiness030217 neurology & neurosurgeryNeuromuscular Disorders
researchProduct

#EEGManyLabs

2021

There is growing awareness across the neuroscience community that the replicability of findings about the relationship between brain activity and cognitive phenomena can be improved by conducting studies with high statistical power that adhere to well-defined and standardised analysis pipelines. Inspired by recent efforts from the psychological sciences, and with the desire to examine some of the foundational findings using electroencephalog-raphy (EEG), we have launched #EEGManyLabs, a large-scale international collaborative replication effort. Since its discovery in the early 20th century, EEG has had a profound in-fluence on our understanding of human cognition, but there is limited evid…

DYNAMICSOpen sciencePREDICTIONNEUROSCIENCESSocial SciencesREPRODUCIBILITY OF RESULTSELECTROENCEPHALOGRAMField (computer science)cognitive neuroscienceCognitionMAGNITUDE0302 clinical medicineREPRODUCIBILITYopen sciencePsychologyEEGPsychology Experimental05 social sciencesHUMANElectroencephalographyHUMANSCognitionTest (assessment)Neuropsychology and Physiological PsychologyNEUROSCIENCERELIABILITYELECTROENCEPHALOGRAPHYPsychologyLife Sciences & BiomedicineBehavioral SciencesERPreplicationHUMAN EXPERIMENTProcess (engineering)Cognitive NeuroscienceExperimental and Cognitive PsychologyCognitive neuroscience050105 experimental psychology03 medical and health sciencesFORECASTINGHumans0501 psychology and cognitive sciencesARTICLEProtocol (science)Science & TechnologyData collectionNeurosciencesATTENTIONReproducibility of ResultsMOTIVATIONData scienceCONTROLLED STUDYSAMPLE-SIZECOGNITIONmany labsNeurosciences & NeurologyREFLECTS030217 neurology & neurosurgeryCortex
researchProduct

Carga global, regional y nacional de neurológicas. Desórdenes, 1990-2016: un análisis sistemático para el Global Estudio de la carga de enfermedad 20…

2019

Publisher´s version (útgefin grein).

DánarmeinMaleEpidemiologyDiseasesMalalties cerebralsGlobal Burden of DiseaseDisability Evaluation0302 clinical medicineCase fatality ratePsychologyKonurCause of deathAged 80 and overeducation.field_of_studyIncidenceMenTaugavísindiddc:3. Good healthSálfræðiWorld healthMuerteNeurologyGBD 2016 Neurology CollaboratorsBrain diseasesQuality-Adjusted Life YearsAlzheimer diseaseCarga global de enfermedadesNervous systemmedicine.medical_specialtyGlobal burden of diseasesLífsgæðiArticle03 medical and health sciencesHealth SciencesHumansWomeneducationTrastornos neurológicosVLAGAgedScience & Technology3112 NeurosciencesGlobal Burden of Diseases030104 developmental biologyYears of potential life lostΕπιστήμες ΥγείαςDementiaHuman medicineNeurosciences & NeurologyNeurology (clinical)Clinical Medicine1109 NeurosciencesNeurological disorders030217 neurology & neurosurgerydementiaRC0301 basic medicinePediatricsDánartíðniNutrition and Disease3124 Neurology and psychiatryDisease StudyTaugasjúkdómarRisk FactorsVoeding en ZiekteCause of DeathGlobal healthPrevalenceNeurological disorders; Global Burden of DiseasesCauses of deathPublic healthMortality rateMental DisordersAge FactorsPublic Health Global Health Social Medicine and EpidemiologyMiddle Agedneurologic diseaseDeathLýðheilsaFemaleLife Sciences & BiomedicineQuality of lifeAdultPopulationClinical NeurologySex FactorsmedicineLife ScienceDisability-adjusted life year:Medicine [Science]MortalityPsychiatryDisease burdenNeurology & Neurosurgeryburden of neurological disordersFaraldsfræðibusiness.industryKlinisk medicinCauses de la mort1103 Clinical SciencesFolkhälsovetenskap global hälsa socialmedicin och epidemiologiSocioeconomic FactorsKarlarglobal disease burdenNervous System DiseasesCause of death/trendsbusiness
researchProduct

Age-Related Changes in Predictive Capacity Versus Internal Model Adaptability: Electrophysiological Evidence that Individual Differences Outweigh Eff…

2015

Hierarchical predictive coding has been identified as a possible unifying principle of brain function, and recent work in cognitive neuroscience has examined how it may be affected by age related changes. Using language comprehension as a test case, the present study aimed to dissociate age-related changes in prediction generation versus internal model adaptation following a prediction error. Event related brain potentials (ERPs) were measured in a group of older adults (60-81 years; n = 40) as they read sentences of the form "The opposite of black is white/yellow/nice." Replicating previous work in young adults, results showed a target related P300 for the expected antonym ("white"; an eff…

Geriatrics & GerontologyCognitive Neuroscienceindividual alpha frequencyAdaptation (eye)Cognitive neuroscienceAffect (psychology)event-related potentialslcsh:RC321-571Developmental psychologyEvent-related potentialN400Effects of sleep deprivation on cognitive performanceYoung adultP300predictive codinglcsh:Neurosciences. Biological psychiatry. NeuropsychiatryOriginal ResearchagingNeurosciencesN400ComprehensionAgeinglate positivityNeurosciences & NeurologyPsychologyNeurosciencelanguage comprehensionFrontiers in Aging Neuroscience
researchProduct

The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT-Adults): Design and methods of an international …

2022

BACKGROUND: . High-quality comprehensive data on short-/long-term physical/mental health effects of the COVID-19 pandemic are needed. METHODS: . The Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) is an international, multi-language (n=30) project involving >230 investigators from 49 countries/territories/regions, endorsed by national/international professional associations. COH-FIT is a multi-wave, on-line anonymous, cross-sectional survey [wave 1: 04/2020 until the end of the pandemic, 12 months waves 2/3 starting 6/24 months threreafter] for adults, adolescents (14-17), and children (6-13), utilizing non-probability/snowball and representative samp…

GerontologyDISORDERSTRESSOutcome AssessmentIMPACT[SDV.MHEP.PSM] Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthRA0421well-beingPandemicHealth careOutcome Assessment Health CareadultsMedicineANXIETYCOVID-19; mental health; functioning; physical health; representative; well-being; resilience; survey; international; psychiatry; depression; anxiety; post-traumatic; COH-FIT; children; adolescents; adultsmental health functioning physical health representative well-being resilience survey international psychiatry depression anxiety post-traumatic COH-FIT children adolescents adultadolescentsChildSCALEPsychiatryeducation.field_of_study[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyPublic Health Global Health Social Medicine and Epidemiologyadolescents; adults; anxiety; children; COH-FIT; COVID-19; depression; functioning; international; mental health; physical health; post-traumatic; psychiatry; representative; resilience; survey; well-being;psychiatryPsychiatry and Mental healthClinical PsychologyrepresentativeinternationaldepressionProfessional associationLife Sciences & Biomedicinemental healthpost-traumaticPsychopathologyResearch PaperAdultCoronavirus disease 2019 (COVID-19)AdolescentPopulationClinical NeurologyBFfunctioningCOH-FIT; COVID-19; adolescents; adults; anxiety; children; depression; functioning; international; mental health; physical health; post-traumatic; psychiatry; representative; resilience; survey; well-being; Adolescent; Adult; Anxiety; Child; Cross-Sectional Studies; Depression; Humans; Mental Health; Outcome Assessment Health Care; SARS-CoV-2; COVID-19; PandemicschildrenIntervention (counseling)MANAGEMENTHumanssurveyVALIDITYeducationPandemicsresilienceScience & Technologybusiness.industrySARS-CoV-2MORTALITYCOVID-19CAREMental healthHealth CareFolkhälsovetenskap global hälsa socialmedicin och epidemiologiCross-Sectional Studies[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthadolescents; adults; anxiety; children; COH-FIT; COVID-19; depression; functioning; international; mental health; physical health; post-traumatic; psychiatry; representative; resilience; survey; well-being; Adolescent; Adult; Anxiety; Child; Cross-Sectional Studies; Depression; Humans; Mental Health; Outcome Assessment Health Care; SARS-CoV-2; COVID-19; PandemicsCOH-FITNeurosciences & Neurologybusinessphysical health[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functionin…

2022

BACKGROUND: The COVID-19 pandemic has altered daily routines and family functioning, led to closing schools, and dramatically limited social interactions worldwide. Measuring its impact on mental health of vulnerable children and adolescents is crucial. METHODS: The Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT - www.coh-fit.com) is an on-line anonymous survey, available in 30 languages, involving >230 investigators from 49 countries supported by national/international professional associations. COH-FIT has thee waves (until the pandemic is declared over by the WHO, and 6-18 months plus 24-36 months after its end). In addition to adults, COH-FIT also…

GerontologyDISORDER[SDV.MHEP.PSM] Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthPsychological intervention*Physical healthAdolescentsHVAdolescents; Children; Covid-19; Mental health; Pandemic; Physical health; ResilienceRA0421PandemicCovid-19; Pandemic; Mental health; Physical health; Resilience; Children; AdolescentsMedicineAdolescents; Children; Covid-19; Mental health; Pandemic; Physical health; Resilience; Adolescent; Adult; Child; Cross-Sectional Studies; Health Promotion; Humans; Mental Health; Pandemics; Quality of Life; SARS-CoV-2; COVID-19ChildChildrenSCALEmedia_commonPsychiatry[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology*PandemicPublic Health Global Health Social Medicine and Epidemiology*ResiliencePsychiatry and Mental healthClinical PsychologyProfessional associationMental healthPsychological resilience*Mental healthCovid-19Life Sciences & BiomedicinePsychopathologyCovid-19 Pandemic Mental health Physical health Resilience Children AdolescentsAdultAdolescent*Adolescentsmedia_common.quotation_subjectClinical NeurologyBFPhysical healthHealth PromotionArticle*ChildrenQuality of life (healthcare)Intervention (counseling)HumansVALIDITYPandemicsScience & TechnologyPandemicResiliencebusiness.industrySARS-CoV-2Mental health*Covid-19Folkhälsovetenskap global hälsa socialmedicin och epidemiologiCross-Sectional Studies[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthQuality of LifeNeurosciences & Neurologybusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis

2021

Key Points Question What genetic variants are associated with juvenile amyotrophic lateral sclerosis (ALS)? Findings In this family-based genetic study, exome sequencing was performed in 3 patients diagnosed with juvenile ALS and failure to thrive; this identified de novo variants in SPTLC1 (p.Ala20Ser in 2 patients and p.Ser331Tyr in 1 patient). Variants in SPTLC1 are a known cause of hereditary sensory and autonomic neuropathy, type 1A, and these data extend the phenotype associated with this gene. Meaning De novo variants in the SPTLC1 gene are associated with juvenile ALS, a fatal neurological disorder.

Hereditary sensory neuropathy; L-serine; Mutations; Deoxysphingolipids; AccumulationEnzyme complexJuvenile amyotrophic lateral sclerosisSerine C-Palmitoyltransferase/dk/atira/pure/subjectarea/asjc/2700/2728Whole Exome Sequencing0302 clinical medicineMedicineFamily historyAmyotrophic lateral sclerosisChildIndex caseExome sequencingOriginal Investigation0303 health sciencesNeurosciences and neurology3. Good healthChild PreschoolFailure to thriveFemalemedicine.symptomLife Sciences & BiomedicineL-SERINECommentsHumanAdultmedicine.medical_specialtyAdolescent; Adult; Amyotrophic Lateral Sclerosis; Child; Child Preschool; Female; Genetic Predisposition to Disease; Humans; Mutation; Serine C-Palmitoyltransferase; Whole Exome Sequencing; Young AdultAdolescentClinical NeurologyNO03 medical and health sciencesYoung AdultDEOXYSPHINGOLIPIDSInternal medicineExome SequencingOnline FirstHumansJuvenileGenetic Predisposition to DiseasePreschool030304 developmental biologyACCUMULATIONScience & TechnologySPTLC1business.industryMUTATIONSResearchAmyotrophic Lateral Sclerosis3112 Neurosciencesmedicine.diseaseHEREDITARY SENSORY NEUROPATHYjuvenileMutation3111 BiomedicineNeurology (clinical)Neurosciences & NeurologyALSgeneticbusiness030217 neurology & neurosurgeryAmyotrophic Lateral Sclerosi
researchProduct

Global, regional, and national burden of stroke and its risk factors, 1990–2019 : a systematic analysis for the Global Burden of Disease Study 2019

2021

Background Regularly updated data on stroke and its pathological types, including data on their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are important for evidence-based stroke care planning and resource allocation. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) aims to provide a standardised and comprehensive measurement of these metrics at global, regional, and national levels. Methods We applied GBD 2019 analytical tools to calculate stroke incidence, prevalence, mortality, disability-adjusted life-years (DALYs), and the population attributable fraction (PAF) of DALYs (with corresponding 95% uncertainty intervals [UIs]…

MaleAging030204 cardiovascular system & hematologyStroke dataGUIDELINES3124 Neurology and psychiatryBody Mass IndexGlobal Burden of Disease0302 clinical medicineRA0421Risk FactorsEpidemiologyStrokesYOUNG-ADULTSPrevalence80 and overAetiology610 Medicine & healthStrokePOPULATION1103 Clinical Sciences 1109 NeurosciencesCause of deathAged 80 and overeducation.field_of_studyMortality rateIncidence (epidemiology)Incidence1. No povertyArticlesHälsovetenskaperMiddle AgedStroke typesddc:3. Good healthStrokeISCHEMIC-STROKEIncomeFemaleQuality-Adjusted Life YearsLife Sciences & BiomedicineAdultmedicine.medical_specialtyGBDPopulationClinical SciencesClinical Neurology610 Medicine & health03 medical and health sciencesClinical ResearchMIDDLE-INCOME COUNTRIESHealth SciencesmedicineHumansRisk factoreducationGBD 2019 Stroke CollaboratorsCerebral HemorrhageAgedIschemic StrokeGlobal burdenScience & TechnologyNeurology & NeurosurgeryHYPERTENSIONbusiness.industryMORTALITYPrevention3112 NeurosciencesNeurosciences1103 Clinical SciencesSERVICESSubarachnoid Hemorrhagemedicine.diseasePREVENTIONBrain DisordersGood Health and Well BeingAttributable riskHuman medicineNeurology (clinical)Neurosciences & Neurologybusiness1109 Neurosciences030217 neurology & neurosurgeryDemography2.4 Surveillance and distributionRC
researchProduct